A FAP-α-activatable near-infrared theranostic probe for fluorescence imaging of pancreatic cancer and potent in vitro photodynamic activity
- 2 December 2025
- journal article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 168, 109326
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (22507091)
- Zhejiang Province Natural Science Foundation (TGD23C040012)
This publication has 24 references indexed in Scilit:
- Serial stimuli-responsive theranostic nanomaterials for cancer therapy and imagingCoordination Chemistry Reviews, 2025
- Second Near‐Infrared Window Fluorescence Materials for In Vivo Dynamic Multiplexed ImagingAdvanced Functional Materials, 2025
- Splicing dysregulation: hallmark and therapeutic opportunity in pancreatic cancerTrends in Molecular Medicine, 2024
- Development of fibroblast activation protein-α radiopharmaceuticals: Recent advances and perspectivesEuropean Journal of Medicinal Chemistry, 2024
- Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studiesMedcomm, 2024
- Improving the dichloro-dihydro-fluorescein (DCFH) assay for the assessment of intracellular reactive oxygen species formation by nanomaterialsNanoImpact, 2024
- Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical studyMedcomm, 2023
- Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironmentSeminars in Cancer Biology, 2022
- A Dual‐Locked Activatable Phototheranostic Probe for Biomarker‐Regulated Photodynamic and Photothermal Cancer TherapyAngewandte Chemie International Edition, 2022
- Recent advances in stimuli‐responsive theranostic systems with aggregation‐induced emission characteristicsAggregate, 2021